RXI Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
RXI Pharmaceuticals Corp
TickerSLS
CIK #0001390478
CUSIP81642T100
SectorLife Sciences - Pharmaceutical Preparations
Address60 Prescott Street, Worcester, MA 01605
Source [EDGAR]
CIK Filing 2011 - 2025
[0001390478] 10-K
[0001390478] 10-Q
[0001390478] 3
[0001390478] 4
[0001390478] 5
[0001390478] 8-K
[0001390478] D
[0001390478] SC 13D
[0001390478] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Sellas Life Sciences Group Inc [2025-07-29] 0.0
Anson Funds Management LP Sellas Life Sciences Group Inc [2025-05-15] 0.0
Highbridge Capital Management LLC Sellas Life Sciences Group Inc [2024-02-07] 6.5
Packer Paul Sellas Life Sciences Group Inc [2020-09-21] 5.3
Hirschman Orin Sellas Life Sciences Group Inc [2020-08-25] 9.9
CVI Investments Inc Sellas Life Sciences Group Inc [2020-01-17] 0.9
Anson Funds Management LP Sellas Life Sciences Group Inc [2019-06-24] 9.7
Renaissance Technologies LLC Sellas Life Sciences Group Inc [2019-02-12] 5.55
Altium Capital Management LP Sellas Life Sciences Group Inc [2018-07-23] 9.81
683 Capital Management LLC Sellas Life Sciences Group Inc [2018-07-23] 0.8
Empery Asset Management LP Sellas Life Sciences Group Inc [2018-07-18] 0.99
Equilibria Capital Management Ltd Sellas Life Sciences Group Inc [2018-01-08] 50.1
Stergiou Angelos M Sellas Life Sciences Group Inc [2018-01-08] 11.0
CVI Investments Inc Galena Biopharma Inc [2017-02-17] 0.3
Ayrton Capital LLC Galena Biopharma Inc [2017-02-17] 4.7
Sabby Management LLC Galena Biopharma Inc [2017-02-15] 4.72
BlackRock Inc Galena Biopharma Inc [2017-01-30] 5.7
CVI Investments Inc Galena Biopharma Inc [2016-07-15] 6.7
Sabby Management LLC Galena Biopharma Inc [2016-07-12] 4.77
BlackRock Inc Galena Biopharma Inc [2014-01-29] 6.3
Sabby Management LLC Galena Biopharma Inc [2013-01-02] 4.1
Form 3/4/5 Filer 2011 - 2025
van Nostrand Robert L
SELLAS Life Sciences Group, Inc.
Wasman Jane
Kalin Katherine Bach
Stergiou Angelos M.
Scheinberg David A
Varian John
Cicic Dragan
Burns John Thomas
Wood Barbara A
Francomano Robert
Sarlis Nicholas J.
Ghiglieri Stephen F
Varibobi Financial Holdings Ltd
Castilian Ltd.
Tafur Daniel
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`
Lopez Fabio
EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fun
Equilibria Capital Management Ltd
EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund
Mack Gene
Torre Gregory M
Krylov Aleksey N.
Einhorn Irving M.
Ashton William
Chin Richard
Nisi Rudolph
Gray Mary Ann
Hillsberg Sanford
Galliker Stephen S
Gerber Sander
Hudson Bay Capital Management LP
Knapp Thomas J
Nejadnik Bijan
Schwartz Mark W
Dunlap Ryan
Kriegsman Steven A
Kivinski Margaret
Hamilton Brian L
Ahn Mark J
Phio Pharmaceuticals Corp.
Mazanet Rosemary
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 6,528,778
BlackRock, Inc. [2025-06-30] SOLE 4,518,310 4,590,273
Marshall Wace LLP [2025-06-30] OTR 0 2,715,489
Caligan Partners LP [2025-06-30] SOLE 2,300,000 2,300,000
Geode Capital Management LLC [2025-06-30] DFND 2,200,428 2,200,428
Susquehanna International Group LLP [2025-06-30] OTR 1,489,672 1,746,772
Millennium Management LLC [2025-06-30] SOLE 1,127,225 1,127,225
State Street Corp [2025-06-30] DFND 982,672 1,112,705
Morgan Stanley [2025-06-30] DFND 545,698 1,084,478
Nuveen, LLC [2025-06-30] DFND 971,329 971,329
Northern Trust Corp [2025-06-30] DFND 683,893 683,893
Citadel Advisors LLC [2025-06-30] DFND 577,893 577,893
Goldman Sachs Group Inc [2025-06-30] DFND 465,506 465,506
GSA Capital Partners LLP [2025-06-30] SOLE 426,584 426,584
Diadema Partners LP [2025-06-30] SOLE 400,000 400,000
UBS Group AG [2025-06-30] DFND 309,687 309,687
Charles Schwab Investment Management Inc [2025-06-30] SOLE 294,106 294,106
Anson Funds Management LP [2025-06-30] DFND 275,000 275,000
Jane Street Group LLC [2025-06-30] DFND 46,682 255,482
Opus Capital Group LLC [2025-06-30] SOLE 240,000 240,000
Bank of New York Mellon Corp [2025-06-30] DFND 197,689 201,460
Two Sigma Investments LP [2025-06-30] SOLE 197,642 197,642
Barclays PLC [2025-06-30] SOLE 172,803 172,803
RhumbLine Advisers [2025-06-30] SOLE 39,430 135,789
Vanguard Group Inc [2025-06-30] DFND 0 126,021
XTX Topco Ltd [2025-06-30] DFND 76,900 76,900
LPL Financial LLC [2025-06-30] SOLE 0 67,560
JPMorgan Chase & Co [2025-06-30] DFND 16,792 61,892
MetLife Investment Management LLC [2025-06-30] DFND 58,844 58,844
Atom Investors LP [2025-06-30] SOLE 54,624 54,624
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com